Solid Tumor Research
Robust molecular profiling from tissue and liquid biopsies
Our solid tumor research panels offer a sensitive targeted sequencing approach for biomarker detection from both liquid and tissue biopsies.
This approach leverages DNA, RNA or ctDNA input types for sensitive characterization of all variant types from low-input clinical research samples.
All Archer panels are powered by Anchored Multiplex PCR (AMP™) chemistry and follow the same simple workflow for maximum efficiency.
Comprehensive Tumor Profiling
Get complete information from your low-input FFPE sample - detect fusions, copy number variations (CNVs), single-nucleotide variant (SNVs), insertions and deletions (indels), RNA expression levels, and microsatellite instability (MSI) status.
Confident Variant Detection
Purpose-built bioinformatics and molecular barcoding powers confident variant detection.
Create from scratch or modify any existing panel to match the pace of discovery.
Partner Agnostic Fusion Detection
RNA-based assays detect both known and novel fusions
NTRK fusion detection in solid tumors
NTRK fusions are critical events in cancer biology, with known and unknown fusion partners that are notoriously difficult to detect. FusionPlex® next-generation sequencing (NGS) panels provide sensitive NTRK fusion detection from RNA without prior knowledge of fusion partners.